Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)

NCT03104478 is registered in ClinicalTrials.gov with The Lymphoma Academic Research Organisation as lead sponsor.

NCT NCT03104478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03104478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
Lead sponsor
The Lymphoma Academic Research Organisation
Phase
Observational
Overall status
Completed
Start date
May 9, 2017
Completion date
September 4, 2021
Enrollment
219 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma